About IVIM
IVIM is a publicly listed company based in Daejeon (South Korea) founded in 2017. Intravital microscopy platforms are developed for in vivo animal imaging. It operates in the Healthcare, Industrial Goods & Manufacturing, and Technology sectors. Its chief executive, as recorded, is Pilhan Kim. Its focus areas include Life Sciences, Imaging Diagnostics, Microscopy and Life Sciences Platforms and Tools. Its legal entity is iBeam Technology Co., Ltd. Its competitors include Park Systems and Tomocube; 1 of its 2 listed competitors has raised funding.
Company details
IVIM was founded in 2017 and is based in Daejeon, South Korea. Operations focus on the biotechnology sector, where intravital microscopy systems are developed for live animal imaging and whole tissue 3D visualization. Products such as the IntraVital Confocal Microscopy System, IntraVital Two-Photon Microscopy System, and dual-mode imaging platform are utilized in in vivo experiments, drug efficacy monitoring, and delivery assessment.
- Headquarters Daejeon, South Korea
- Stage Public
- SectorsHealthcareIndustrial Goods & Manufacturing Technology
- Email••••••••
- Phone•••• ••••
- Website ivimtech.com
- Social LinkedIn Facebook YouTube
- Legal Name Ivim Technology, Inc.
- Annual Revenue$3.03 M (USD)22.77as on Dec 31, 2025
- Net Profit-$2.63 M (USD)5.02as on Dec 31, 2025
- EBITDA-$1.59 M (USD)21.55as on Dec 31, 2025
Apps and channels of IVIM
its YouTube channel IVIM Technology has 516 subscribers and 30 videos.
Videos from IVIM
The most watched videos on IVIM's YouTube channel, IVIM Technology (516 subscribers). Click a video to play it here.
More on IVIM Technology.
People of IVIM
1 people are tracked at IVIM (1 in leadership).
| Name | Role | Group |
|---|---|---|
Pilhan Kim | CEO | Leadership |
Complete people profiles for IVIM
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of IVIM
IVIM is a publicly listed company on the KRX with ticker symbol 460470 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date06 Aug 2024
- Listed onKRX: 460470
- Listed entityIVIM Technology, Inc.
- Exchange sectorHealth technology
- ISINKR7460470008
- Share price2,775.00 KRW (-0.54% on the day) · 2026-10-14
- Market capitalisation42,183,043,585.00 KRW
- EPS (diluted, trailing year)-177.51 KRW
- Volume (last session)4,742
Financials of IVIM
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 4.38B KRW | -3.80B KRW | -2.30B KRW |
| 2024 | 3.56B KRW | -4.00B KRW | -2.93B KRW |
| 2023 | 4.50B KRW | -5.04B KRW | -1.80B KRW |
| 2022 | 1.34B KRW | -9.74B KRW | -2.47B KRW |
| 2021 | 527.0M KRW | -2.62B KRW | -2.04B KRW |
Detailed financial statements for IVIM
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of IVIM
IVIM has 2 listed competitors in our database, 1 of them funded. They include Park Systems and Tomocube.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| parksystems.com | 1997 | Suwon-si, South Korea | Scanning probe microscopes are manufactured for nanoimaging applications. | |||
| tomocube.com | 2015 | Daejeon, South Korea | $2M | Holographic microtomography is utilized for live cell imaging in microscopy. |
Detailed competitors of IVIM
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IVIM
The website of IVIM (ivimtech.com) receives about 4.1K visits a month.
- Monthly visits4.1K
▲ 4.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ivim
Complete news archive for IVIM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IVIM
IVIM was founded in 2017.
IVIM is headquartered in Daejeon, South Korea.
Pilhan Kim is the CEO of IVIM, as recorded in our data.
Annual revenue of IVIM is $3.03M as on Dec 31, 2025.
IVIM was founded in 2017 and is based in Daejeon, South Korea. Operations focus on the biotechnology sector, where intravital microscopy systems are developed for live animal imaging and whole tissue 3D visualization. Products such as the IntraVital Confocal Microscopy System, IntraVital Two-Photon Microscopy System, and dual-mode imaging platform are utilized in in vivo experiments, drug efficacy monitoring, and delivery assessment.
IVIM's top competitors include Park Systems and Tomocube.
Yes, IVIM is publicly traded on KRX under the ticker symbol 460470.
IVIM operates through Ibeam Technology Co., Ltd..